BIOMAT Database Logo BIOMAT Database Logo

Studies with phenylbutazone, oxyphenbutazone, and para-paradichloro phenylbutazone in horses. 1969

C P Gandal, and P G Dayton, and M Weiner, and J M Perel

UI MeSH Term Description Entries
D010113 Oxyphenbutazone A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27) Hydroxyphenylbutazone,Diflamil,Oxyphenylbutazone,Tanderil
D010653 Phenylbutazone A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS. Diphenylbutazone,Fenilbutazon,Butacote,Butadion,Butadione,Butapirazol,Butapyrazole,Butazolidin
D006736 Horses Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest. Equus caballus,Equus przewalskii,Horse, Domestic,Domestic Horse,Domestic Horses,Horse,Horses, Domestic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013442 Sulfinpyrazone A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties. Sulfoxyphenylpyrazolidin,Anturan,Anturane,Apo-Sulfinpyrazone,Nu-Sulfinpyrazone,Sulphinpyrazone,Apo Sulfinpyrazone,Nu Sulfinpyrazone

Related Publications

C P Gandal, and P G Dayton, and M Weiner, and J M Perel
Phenylbutazone and oxyphenbutazone.
April 1973, The Medical letter on drugs and therapeutics,
C P Gandal, and P G Dayton, and M Weiner, and J M Perel
[Clinical and experimental studies on phenylbutazone and oxyphenbutazone].
August 1965, Arzneimittel-Forschung,
C P Gandal, and P G Dayton, and M Weiner, and J M Perel
Population distributions of phenylbutazone and oxyphenbutazone after oral and i.v. dosing in horses.
December 1984, Journal of veterinary pharmacology and therapeutics,
C P Gandal, and P G Dayton, and M Weiner, and J M Perel
Pharmacokinetic and pharmacodynamic studies on phenylbutazone and oxyphenbutazone in goats.
January 1997, The Veterinary record,
C P Gandal, and P G Dayton, and M Weiner, and J M Perel
Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
January 1997, American journal of veterinary research,
C P Gandal, and P G Dayton, and M Weiner, and J M Perel
Phenylbutazone, oxyphenbutazone labeling revised.
December 1984, FDA drug bulletin,
C P Gandal, and P G Dayton, and M Weiner, and J M Perel
Phenylbutazone, oxyphenbutazone and aplastic anaemia.
July 1977, British medical journal,
C P Gandal, and P G Dayton, and M Weiner, and J M Perel
Studies of the interaction of phenylbutazone, oxyphenbutazone and methandrostenolone in man.
November 1968, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
C P Gandal, and P G Dayton, and M Weiner, and J M Perel
[Studies on the effects of oxyphenbutazone and phenylbutazone on hepatic lysosomes].
September 1972, Klinische Wochenschrift,
C P Gandal, and P G Dayton, and M Weiner, and J M Perel
[Interactions of phenylbutazone and oxyphenbutazone with glymidine (author's transl)].
January 1981, Arzneimittel-Forschung,
Copied contents to your clipboard!